BiondVax Pharmaceuticals Ltd (BVXV):企業の財務・戦略的SWOT分析

◆英語タイトル:BiondVax Pharmaceuticals Ltd (BVXV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15060
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BiondVax Pharmaceuticals Ltd (BiondVax Pharmaceuticals) is a biopharmaceutical company that develops universal flu vaccine. The company provides lead product M-001 is a synthetic peptide-based protein that offers protection against human influenza virus strains including seasonal influenza strains; and pandemic influenza strains such as swine flu and avian flu. Its vaccine helps to provide multi-strain, multi season and long-term protection against various flu viruses. BiondVax Pharmaceuticals uses synthetic peptides in vaccines which offers practical advantages such as relative ease of production, chemical stability, and an avoidance of any infectious or oncogenic potential hazard. The company operates in Israel. BiondVax is headquartered in Ness Ziona, Israel.

BiondVax Pharmaceuticals Ltd Key Recent Developments

Nov 13,2018: BiondVax announces third quarter 2018 financial results
Nov 13,2018: BiondVax Issues Clarification Regarding Third Quarter 2018 Financial Results
Oct 24,2018: BiondVax’s Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season’s Enrollment of 4,098 Participants
Oct 22,2018: BiondVax Receives 8M From the European Investment Bank (EIB) in Support of Manufacturing Facility and Ongoing Phase 3 Clinical Trial
Aug 22,2018: BiondVax Pharmaceuticals reports second quarter 2018 financial results

This comprehensive SWOT profile of BiondVax Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BiondVax Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

BiondVax Pharmaceuticals Ltd – Key Information
BiondVax Pharmaceuticals Ltd – Overview
BiondVax Pharmaceuticals Ltd – Key Employees
BiondVax Pharmaceuticals Ltd – Key Employee Biographies
BiondVax Pharmaceuticals Ltd – Key Operational Heads
BiondVax Pharmaceuticals Ltd – Major Products and Services
BiondVax Pharmaceuticals Ltd – History
BiondVax Pharmaceuticals Ltd – Company Statement
BiondVax Pharmaceuticals Ltd – Locations And Subsidiaries
BiondVax Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

BiondVax Pharmaceuticals Ltd – Business Description
BiondVax Pharmaceuticals Ltd – Corporate Strategy
BiondVax Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
BiondVax Pharmaceuticals Ltd – Strengths
BiondVax Pharmaceuticals Ltd – Weaknesses
BiondVax Pharmaceuticals Ltd – Opportunities
BiondVax Pharmaceuticals Ltd – Threats
BiondVax Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

BiondVax Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

BiondVax Pharmaceuticals Ltd, Key Information
BiondVax Pharmaceuticals Ltd, Key Ratios
BiondVax Pharmaceuticals Ltd, Share Data
BiondVax Pharmaceuticals Ltd, Major Products and Services
BiondVax Pharmaceuticals Ltd, History
BiondVax Pharmaceuticals Ltd, Key Employees
BiondVax Pharmaceuticals Ltd, Key Employee Biographies
BiondVax Pharmaceuticals Ltd, Key Operational Heads
BiondVax Pharmaceuticals Ltd, Other Locations
BiondVax Pharmaceuticals Ltd, Subsidiaries
BiondVax Pharmaceuticals Ltd, Key Manufacturing facilities
BiondVax Pharmaceuticals Ltd, Key Competitors
BiondVax Pharmaceuticals Ltd, SWOT Analysis
BiondVax Pharmaceuticals Ltd, Ratios based on current share price
BiondVax Pharmaceuticals Ltd, Annual Ratios
BiondVax Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

BiondVax Pharmaceuticals Ltd, Performance Chart
BiondVax Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[BiondVax Pharmaceuticals Ltd (BVXV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Optivia Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Optivia Biotechnology Inc (Optivia Biotechnology), a subsidiary of BioIVT, is a contract research organization that offers drug transporter research services and solutions. The organization offers products such as single transporter assay plates, multi-transporter model plates and verified e …
  • Delfi Limited:企業の戦略・SWOT・財務情報
    Delfi Limited - Strategy, SWOT and Corporate Finance Report Summary Delfi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Marubeni Corporation:企業の戦略・SWOT・財務情報
    Marubeni Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubeni Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sumitomo Metal Mining Co Ltd:戦略・SWOT・企業財務分析
    Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mytilineos Holdings Sa:企業の戦略・SWOT・財務分析
    Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report Summary Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kuraray Co., Ltd.:企業の戦略・SWOT・財務情報
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Day & Zimmermann Group, Inc.:企業の戦略・SWOT・財務分析
    Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • VertiFlex Inc:医療機器:M&Aディール及び事業提携情報
    Summary VertiFlex Inc (Vertiflex) is a medical device company that offers invasive treatments for lumbar stenosis. The company offers products such as interspinous spacer and direct decompression systems. Its interspinous spacer system is a motion-preserving, indirect decompression spinal implant sy …
  • The Ultimate Software Group Inc (ULTI):企業の財務・戦略的SWOT分析
    The Ultimate Software Group Inc (ULTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Pancontinental Oil & Gas NL (PCL):企業の財務・戦略的SWOT分析
    Summary Pancontinental Oil & Gas NL (Pancontinental) is an oil and gas exploration and production company. The company carries out acquisition, exploration and development of conventional oil and gas properties. The company offers projects such as Namibia Walvis Basin EL 0037, Kenya Lamu Basin L6, T …
  • Imperial Metals Corporation:企業の戦略・SWOT・財務情報
    Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • NV Energy Inc:電力:M&Aディール及び事業提携情報
    Summary NV Energy Inc (NVE) is an energy holding company, which provides a wide range of services through its principal subsidiaries, Nevada Power Co and Sierra Pacific Power Co. NVE delivers electricity to residential, commercial and industrial customers. It also sells electricity and natural gas t …
  • Emmi AG:企業のM&A・事業提携・投資動向
    Emmi AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Emmi AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Proteome Sciences Plc (PRM):医療機器:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • Darling Ingredients Inc.:企業のM&A・事業提携・投資動向
    Darling Ingredients Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Darling Ingredients Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Brunei National Petroleum Co Sdn Bhd:石油・ガス:M&Aディール及び事業提携情報
    Summary Brunei National Petroleum Co Sdn Bhd (PetroleumBRUNEI) is an oil and gas company that provides exploration and production of oil and gas. The company offers engineering, procurement, construction, installation, commissioning services, and others. It provides oilfield services, onshore and of …
  • Younicos AG:電力:M&Aディール及び事業提携情報
    Summary Younicos AG (Younicos), a subsidiary of Aggreko Plc, is a provider of smart energy and grid solutions based on battery storage technology. The company offers Y-Cube plug and play energy storage solution, Y-Station building solution, and Y-Q software platform. It also provides battery packs u …
  • Hallador Energy Co (HNRG):企業の財務・戦略的SWOT分析
    Hallador Energy Co (HNRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ten Network Holdings Ltd:企業の戦略的SWOT分析
    Ten Network Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • OncoSil Medical Ltd (OSL)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆